One Gene Therapy, Many Mutations: Could the FDA Make Rare-Disease Treatments Easier to Develop?
In Simple Terms The FDA is considering a way to let developers adapt one gene therapy for people with different genetic changes, instead of starting over with a completely new study for every version. That…


































































































